| [1] |
FOWLER J R,MAANI E V,JACK B W. Cervical Cancer[M]. Treasure Island (FL):StatPearls Publishing,2021.
|
| [2] |
BRAY F, FERLAY J, SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424. DOI:10.3322/caac.21492.
|
| [3] |
Comprehensive cervical cancer control:a guide to essential practice[M]. 2nd ed. Geneva:World Health Organization,2014.
|
| [4] |
HULL R, MBELE M, MAKHAFOLA T,et al. Cervical cancer in low and middle-income countries[J]. Oncol Lett,2020,20(3):2058-2074. DOI:10.3892/ol.2020.11754.
|
| [5] |
BHATLA N, DENNY L. FIGO cancer report 2018[J]. Int J Gynecol Obstet,2018,143:2-3. DOI:10.1002/ijgo.12608.
|
| [6] |
Corrigendum to "Revised FIGO staging for carcinoma of the cervix uteri" [J]. Int J Gynaecol Obstet,2019,147(2):279-280. DOI:10.1002/ijgo.12969.
|
| [7] |
王登凤,张国楠. FIGO 2018年子宫颈癌分期的重要更正提示[J]. 中国实用妇科与产科杂志,2020,36(9):905-906. DOI:10.19538/j.fk2020090126.
|
| [8] |
刘萍,李朋飞. 子宫颈癌治疗前评估的规范化[J]. 中国实用妇科与产科杂志,2021,37(1):41-44. DOI:10.19538/j.fk2021010110.
|
| [9] |
KHIEWVAN B, TORIGIAN D A, EMAMZADEHFARD S,et al. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer[J]. Hell J Nucl Med,2016,19(3):254-268. DOI:10.1967/s002449910409.
|
| [10] |
SONG J, HU Q, HUANG J,et al. Combining tumor size and diffusion-weighted imaging to diagnose normal-sized metastatic pelvic lymph nodes in cervical cancers[J]. Acta Radiol,2019,60(3):388-395. DOI:10.1177/0284185118780903.
|
| [11] |
董诗洁,胡晓欣,王葳,等. 基于多序列MRI与多体系影像组学模型预测子宫颈癌淋巴结转移的研究[J]. 中国癌症杂志,2021,31(6):460-467. DOI:10.19401/j.cnki.1007-3639.2021.06.004.
|
| [12] |
CHEN J, HE B, DONG D,et.al. Noninvasive CT radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinoma[J]. Br J Radiol,2020,93(1108):20190558. DOI:10.1259/bjr.20190558.
|
| [13] |
中国抗癌协会妇科肿瘤专业委员会.子宫颈癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志,2021,31(6):474-489. DOI:10.19401/j.cnki.1007-3639.2021.06.06.
|
| [14] |
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology:cervical cancer(version I.2021)[EB/OL]. [2021-10-10]. .
|
| [15] |
MARTH C, LANDONI F, MAHNER S,et al. Corrections to "Cervical cancer:ESMO Clinical Practice Guidelines for diagnosis,treatment and follow-up"[J]. Ann Oncol,2018,29():iv262. DOI:10.1093/annonc/mdy160.
|
| [16] |
朱俊,吴小华.2020年度妇科恶性肿瘤最新研究进展及展望[J]. 中国癌症杂志,2021,31(4):250-256. DOI:10.19401/j.cnki.1007-3639.2021.04.002.
|
| [17] |
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology:cervical cancer(version I.2018)[EB/OL]. [2021-10-10]. .
|
| [18] |
RAMIREZ P T, FRUMOVITZ M, PAREJA R,et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer[J]. N Engl J Med,2018,379(20):1895-1904. DOI:10.1056/nejmoa1806395.
|
| [19] |
MELAMED A, MARGUL D J, CHEN L,et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer[J]. N Engl J Med,2018,379(20):1905-1914. DOI:10.1056/NEJMoa1804923.
|
| [20] |
马骏,陈晓林,王倩青,等. ⅠA1(LVSI+)~ⅡA1期子宫颈癌腹腔镜与开腹手术长期肿瘤学结局的真实世界研究[J]. 中国实用妇科与产科杂志,2020,36(5):445-452. DOI:10.19538/j.fk2020050115.
|
| [21] |
中华医学会妇科肿瘤学分会.宫颈癌微创手术的中国专家共识[J]. 现代妇产科进展,2019,28(11):801-803. DOI:10.13283/j.cnki.xdfckjz.2019.11.001.
|